Latest News of RXT
Zai Lab presents positive outcomes from KarXT Phase III trial for schizophrenia
By Yahoo! Finance |
1 week ago
Zai Lab's Phase III trial of KarXT for schizophrenia in China showed positive outcomes, meeting primary and secondary endpoints. The trial demonstrated the potential of KarXT as a new treatment option...